Literature DB >> 7781382

Occult hypercarbia. An unrecognized phenomenon during percutaneous endoscopic tracheostomy.

P M Reilly1, H L Anderson, R F Sing, C W Schwab, R H Bartlett.   

Abstract

Bronchoscopy has been incorporated as a useful adjunct to increase the safety and effectiveness of percutaneous endoscopic tracheostomy (PET). Insertion of the bronchoscope, along with the intraluminal dilators of the PET set, into the airway potentially leads to hypoventilation and hypercarbia during the procedure. Using continuous in-line arterial blood gas monitoring, we documented profound hypercarbia in two patients undergoing PET in the surgical ICU. In a third patient, the rise in PaCO2 was accompanied by a marked rise in intracranial pressure (ICP), and a corresponding fall in cerebral perfusion pressure. While transient hypercarbia seems well tolerated by most patients, this phenomenon and its effect on cerebral blood flow should be strongly considered before performing PET on the critically ill patient with evidence of elevated ICP.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7781382     DOI: 10.1378/chest.107.6.1760

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  15 in total

1.  Effect of percutaneous tracheostomy on intracerebral pressure and perfusion pressure in patients with acute cerebral dysfunction (TIP Trial): an observational study.

Authors:  Jens Kleffmann; Roman Pahl; Wolfgang Deinsberger; Andreas Ferbert; Christian Roth
Journal:  Neurocrit Care       Date:  2012-08       Impact factor: 3.210

2.  Hypercarbia during tracheostomy.

Authors:  M Gemma; S Cozzi; A Cipriani
Journal:  Intensive Care Med       Date:  1998-03       Impact factor: 17.440

3.  Comparison of EtView™ tracheoscopic ventilation tube and video-assisted fiberoptic bronchoscopy during percutaneous dilatational tracheostomy.

Authors:  Tarik Umutoglu; Mefkur Bakan; Ufuk Topuz; Sinan Yilmaz; Kadir Idin; Selcuk Alver; Erdogan Ozturk; Ziya Salihoglu
Journal:  J Clin Monit Comput       Date:  2016-04-29       Impact factor: 2.502

Review 4.  Percutaneous versus surgical strategy for tracheostomy: a systematic review and meta-analysis of perioperative and postoperative complications.

Authors:  Rosa Klotz; Pascal Probst; Marlene Deininger; Ulla Klaiber; Kathrin Grummich; Markus K Diener; Markus A Weigand; Markus W Büchler; Phillip Knebel
Journal:  Langenbecks Arch Surg       Date:  2017-12-27       Impact factor: 3.445

5.  Ultrasound-guided percutaneous tracheostomy in critically ill obese patients.

Authors:  Pierre-Grégoire Guinot; Elie Zogheib; Sandra Petiot; Jean-Pierre Marienne; Anne-Marie Guerin; Pauline Monet; Rody Zaatar; Hervé Dupont
Journal:  Crit Care       Date:  2012-12-12       Impact factor: 9.097

6.  Open Tracheostomy after Aborted Percutaneous Approach due to Tracheoscopy Revealing Occult Tracheal Wall Ulcer.

Authors:  John Schweiger; Collin Sprenker; Devanand Mangar; Rachel Karlnoski; Naga Pullakhandam; Enrico M Camporesi
Journal:  Case Rep Anesthesiol       Date:  2013-07-17

7.  Real-time ultrasound-guided percutaneous dilatational tracheostomy: a feasibility study.

Authors:  Venkatakrishna Rajajee; Jeffrey J Fletcher; Lauryn R Rochlen; Teresa L Jacobs
Journal:  Crit Care       Date:  2011-02-22       Impact factor: 9.097

8.  A technical modification for percutaneous tracheostomy: prospective case series study on one hundred patients.

Authors:  Joao B Rezende-Neto; Argenil J Oliveira; Mario P Neto; Fernando A Botoni; Sandro B Rizoli
Journal:  World J Emerg Surg       Date:  2011-11-02       Impact factor: 5.469

Review 9.  Clinical review: percutaneous dilatational tracheostomy.

Authors:  Mariam A Al-Ansari; Mohammed H Hijazi
Journal:  Crit Care       Date:  2006-02       Impact factor: 9.097

Review 10.  Use of ultrasound guidance to improve the safety of percutaneous dilatational tracheostomy: a literature review.

Authors:  Mariam Alansari; Hadil Alotair; Zohair Al Aseri; Mohammed A Elhoseny
Journal:  Crit Care       Date:  2015-05-18       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.